ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 52 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2017. The put-call ratio across all filers is 25.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $112,000 | -25.3% | 11,884 | -42.3% | 0.01% | -8.3% |
| Q2 2018 | $150,000 | -80.1% | 20,591 | -86.4% | 0.01% | -72.1% |
| Q1 2018 | $755,000 | -42.8% | 151,078 | -42.2% | 0.04% | -55.2% |
| Q4 2017 | $1,320,000 | -14.8% | 261,326 | +4.5% | 0.10% | -5.9% |
| Q3 2017 | $1,550,000 | +14.6% | 250,015 | -33.5% | 0.10% | +13.3% |
| Q2 2017 | $1,353,000 | -2.7% | 375,854 | -12.2% | 0.09% | -21.7% |
| Q1 2017 | $1,391,000 | +27.8% | 427,967 | -3.6% | 0.12% | +11.7% |
| Q4 2016 | $1,088,000 | -99.0% | 443,887 | +311.0% | 0.10% | -65.7% |
| Q3 2016 | $107,990,000 | +48764.3% | 107,990 | +69.9% | 0.30% | +934.5% |
| Q2 2016 | $221,000 | +79.7% | 63,550 | +113.6% | 0.03% | +70.6% |
| Q1 2016 | $123,000 | -45.6% | 29,754 | -19.9% | 0.02% | -54.1% |
| Q3 2015 | $226,000 | – | 37,135 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |